Interstitial lung disease in polymyositis and dermatomyositis

Area of Science:

• Rheumatology
• Pulmonology
• Internal Medicine

Background:

• Polymyositis and dermatomyositis are idiopathic inflammatory myopathies.
• Interstitial lung disease (ILD) can be a significant complication of these conditions.

Purpose of the Study:

• To investigate the frequency and characteristics of diffuse interstitial lung disease (DILD) in patients with polymyositis and dermatomyositis.
• To explore potential factors associated with DILD development and outcomes.

Main Methods:

• Retrospective review of 15 patients diagnosed with polymyositis or dermatomyositis over a 7-year period.
• Analysis of clinical data, including serum enzyme levels (creatine phosphokinase, aldolase), muscle biopsy findings, and presence/severity of DILD.

Main Results:

• Diffuse interstitial lung disease (DILD) was identified in 7 out of 15 patients (47%).
• Patients with DILD exhibited higher creatine phosphokinase and aldolase levels and more severe muscle necrosis compared to those without DILD.
• Early corticosteroid therapy that normalized enzyme levels was associated with better DILD resolution.
• Active muscle necrosis appeared to be a risk factor for DILD development.

Conclusions:

• Diffuse interstitial lung disease (DILD) is a common manifestation in polymyositis and dermatomyositis.
• Muscle necrosis severity and elevated muscle enzymes are associated with DILD in these patients.
• Prompt and adequate corticosteroid treatment may improve DILD prognosis.